|
11.
|
|
11 p, 1.4 MB |
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
/
Barbui, Tiziano (Papa Giovanni XXIII Hospital. FROM Research Foundation) ;
De Stefano, Valerio (Fondazione Policlinico "A. Gemelli" IRCCS. Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University) ;
Alvarez-Larran, Alberto (Hospital Clínic i Provincial de Barcelona) ;
Iurlo, Alessandra (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico. Hematology Division) ;
Masciulli, Arianna (Papa Giovanni XXIII Hospital. FROM Research Foundation) ;
Carobbio, Alessandra (Papa Giovanni XXIII Hospital. FROM Research Foundation) ;
Ghirardi, Arianna (Papa Giovanni XXIII Hospital. FROM Research Foundation) ;
Ferrari, Alberto (Papa Giovanni XXIII Hospital. FROM Research Foundation) ;
Cancelli, Valeria (Spedali Civili) ;
Elli, Elena Maria (Ospedale San Gerardo (Itàlia)) ;
Andrade-Campos, Marcio Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Kabat, Mercedes Gasior (Hospital Universitario La Paz (Madrid)) ;
Kiladjian, Jean-Jaques (Hospital Saint-Louis) ;
Palandri, Francesca (Azienda Ospedaliero-Universitaria di Bologna) ;
Benevolo, Giulia (AOU Città della Salute e della Scienza di Torino) ;
Garcia-Gutierrez, Valentin (Hospital Universitario Ramón y Cajal (Madrid)) ;
Fox, Maria Laura (Vall d'Hebron Institut d'Oncologia) ;
Foncillas, Maria Angeles (Hospital Universitario Infanta Leonor) ;
Morcillo, Carmen Montoya (Complejo Hospitalario Universitario de Albacete) ;
Rumi, Elisa (University of Pavia. Department of molecular medicine) ;
Osorio, Santiago (Hospital General Universitario Gregorio Marañón) ;
Papadopoulos, Petros (Hospital Clínico San Carlos (Madrid)) ;
Bonifacio, Massimiliano (Ospedale Policlinico "G.B. Rossi", Borgo Roma) ;
Quiroz Cervantes, Keina (Hospital Universitario de Móstoles (Madrid)) ;
Serrano, Miguel Sagues (Hospital de Sant Joan Despí Moisès Broggi) ;
Carreño-Tarragona, Gonzalo (Hospital Universitario 12 de Octubre (Madrid)) ;
Sobas, Marta Anna (Wroclaw Medical University. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation) ;
Lunghi, Francesca (IRCCS Ospedale San Raffaele) ;
Patriarca, Andrea (AOU Maggiore della Carità, Novara, Italy) ;
Elorza, Begoña Navas (Hospital Moncloa, Madrid, Spain) ;
Angona, Anna (Hospital Universitari de Girona Doctor Josep Trueta) ;
Mazo, Elena Magro (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Koschmieder, Steffen (RWTH Aachen University. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine) ;
Carli, Giuseppe (Ospedale San Bortolo) ;
Cuevas, Beatriz (Hospital Universitario de Burgos) ;
Hernandez-Boluda, Juan Carlos (Hospital Clínic Universitari (València)) ;
Abadia, Emma Lopez (Hospital General Universitario de Elche) ;
Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Guglielmelli, Paola (University of Florence. Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi) ;
Garrote, Marta (Hospital Clínic i Provincial de Barcelona) ;
Cattaneo, Daniele (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico. Hematology Division) ;
Daffini, Rosa (Spedali Civili) ;
Cavalca, Fabrizio (Ospedale San Gerardo (Itàlia)) ;
Bellosillo Paricio, Beatriz (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Benajiba, Lina (Hospital Saint-Louis) ;
Curto-Garcia, Natalia (Guy's and St. Thomas' NHS Foundation Trust) ;
Bellini, Marta (ASST Papa Giovanni XXIII, Bergamo, Italy) ;
Betti, Silvia (Fondazione Policlinico "A. Gemelli" IRCCS. Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University) ;
Harrison, Claire (Guy's and St. Thomas' NHS Foundation Trust) ;
Rambaldi, Alessandro (Università degli Studi di Milano) ;
Vannucchi, Alessandro Maria (University of Florence. Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi) ;
Universitat Autònoma de Barcelona
In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, n = 48), polycythemia vera (PV, n = 42), myelofibrosis (MF, n = 56), and prefibrotic myelofibrosis (pre-PMF, n = 16), 15 major thromboses (3 arterial and 12 venous) were registered in 14 patients, of whom all, but one, were receiving LMW-heparin prophylaxis. [...]
2021 -  10.1038/s41408-021-00417-3
Blood Cancer Journal, Vol. 11 (february 2021)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
